Pulmonary
Greg Martin, MD, MSc, FCCM (he/him/his)
Emory University, Georgia
Disclosure(s): Elsevier Publishing: Other Financial or Material Support (Ongoing); UpToDate: Other Financial or Material Support (Ongoing)
Acute respiratory distress syndrome (ARDS) continues to pose significant challenges in critical care, with high morbidity and mortality despite ongoing therapeutic advances. This session offers a focused exploration of biomarkers and their evolving role in ARDS pathophysiology and management. Attendees will gain a clear understanding of the review’s key findings, including how biomarkers illuminate disease mechanisms and inform clinical decision-making. The session will also evaluate current applications of biomarkers in practice, featuring insights from clinical trials and point-of-care technologies. Join us to discover how biomarker-driven strategies are shaping the future of ARDS care and advancing precision medicine in the ICU.
Pratik Sinha, PhD, MB, ChB, FRCEM – Washington University School Of Medicine
Lorraine Ware, MD (she/her/hers) – Vanderbilt University